Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)6953-6957
Number of pages5
JournalAnnals of surgical oncology
Volume30
Issue number12
DOIs
StatePublished - Nov 2023

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this